Biocon Biologics secures multiple market access agreements in US for YesintekBiocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 million lives. Mult...
05 May, 2025, 10.38 AM IST
Biocon shares in focus after successful results of Yesintek in Phase 3Biocon's shares have risen by 18.31% over the past year. However, year-to-date (YTD), the stock has dropped by 9.59%. In the last six month...
10 Mar, 2025, 09.15 AM IST
Biocon shares in focus after subsidiary launches biosimilar alternative to Stelara in the USBiocon Biologics has launched YESINTEK, a biosimilar to Stelara, in the United States for treating chronic autoimmune conditions, offering ...
25 Feb, 2025, 08.54 AM IST
Stocks in news: ONGC, NTPC, SBI Life, Manappuram Finance, BioconNTPC along with its arm NTPC Green Energy signed multiple MoUs with Madhya Pradesh government to invest over Rs 2 lakh crore in the state.
25 Feb, 2025, 06.23 AM IST
Stocks in news: Vedanta, Dixon Tech, Bharat Forge, ONGC, RILDixon Technologies and Chinese smartphone maker Vivo are entering into a joint venture that will manufacture smartphones for the smartphone...
16 Dec, 2024, 06.58 AM IST
Stocks in news: Greaves Cotton, Biocon, Tata Motors, Hyundai, CiplaMarkets advanced nearly 1% last week, recording a two-week rally. Focus today includes Greaves Cotton's IPO plan for its subsidiary, Biocon...
02 Dec, 2024, 07.02 AM IST
Biocon Biologics gets US nod to launch Stelara biosimilarBiocon Biologics has secured USFDA approval to launch the biosimilar of Janssen's Stelara by February 2025, targeting autoimmune conditions...
01 Dec, 2024, 08.24 PM IST